0001104659-24-072998.txt : 20240618 0001104659-24-072998.hdr.sgml : 20240618 20240618212249 ACCESSION NUMBER: 0001104659-24-072998 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230314 FILED AS OF DATE: 20240618 DATE AS OF CHANGE: 20240618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Neill Vincent CENTRAL INDEX KEY: 0001672718 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38410 FILM NUMBER: 241053833 MAIL ADDRESS: STREET 1: 2150 WOODWARD ST., SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioXcel Therapeutics, Inc. CENTRAL INDEX KEY: 0001720893 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821386754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 555 LONG WHARF DRIVE CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-643-8060 MAIL ADDRESS: STREET 1: 555 LONG WHARF DRIVE CITY: NEW HAVEN STATE: CT ZIP: 06511 4/A 1 tm2417544-3_4aseq1.xml OWNERSHIP DOCUMENT X0508 4/A 2023-03-14 2023-03-16 0 0001720893 BioXcel Therapeutics, Inc. BTAI 0001672718 O'Neill Vincent C/O BIOXCEL THERAPEUTICS, INC. 555 LONG WHARF DRIVE, 12TH FLOOR NEW HAVEN CT 06511 0 1 0 0 See Remarks 0 Common Stock 3158 D Restricted Stock Units Common Stock 0 0 D Stock Option (Right to Buy) Common Stock 0 0 D This amendment is being filed to correct the amount previously reported in the Form 4 filed on March 16, 2023 (the "Original Form 4") that inadvertently reported an award of (i) 9,000 restricted stock units ("RSUs") and (ii) options to purchase 32,000 shares of the Issuer's common stock (the "Options"). The Reporting Person was not granted such RSUs and Options and does not beneficially own any shares underlying the awards reported on the Original Form 4. Executive Vice President, Chief of Product Development and Medical Officer /s/ Richard Steinhart, as Attorney-in-Fact for Vincent O'Neill 2024-06-18